Related Experiment Video
Updated: May 22, 2026
Subtype-selective Electroporation of Cortical Interneurons
Published on: August 18, 2014
Egr-1 induces DARPP-32 expression in striatal medium spiny neurons via a conserved intragenic element
Serene Keilani1, Samira Chandwani, Georgia Dolios
1Department of Neurology and Pediatrics, Mount Sinai School of Medicine, New York, New York 10029, USA.
Abstract:
DARPP-32 (dopamine and adenosine 3', 5'-cyclic monophosphate cAMP-regulated phosphoprotein, 32 kDa) is a striatal-enriched protein that mediates signaling by dopamine and other first messengers in the medium spiny neurons. The transcriptional mechanisms that regulate striatal DARPP-32 expression remain enigmatic and are a subject of much interest in the efforts to induce a striatal phenotype in stem cells. We report the identification and characterization of a conserved region, also known as H10, in intron IV of the gene that codes for DARPP-32 (Ppp1r1b). This DNA sequence forms multiunit complexes with nuclear proteins from adult and embryonic striata of mice and rats. Purification of proteins from these complexes identified early growth response-1 (Egr-1). The interaction between Egr-1 and H10 was confirmed in vitro and in vivo by super-shift and chromatin immunoprecipitation assays, respectively. Importantly, brain-derived neurotrophic factor (BDNF), a known inducer of DARPP-32 and Egr-1 expression, enhanced Egr-1 binding to H10 in vitro. Moreover, overexpression of Egr-1 in primary striatal neurons induced the expression of DARPP-32, whereas a dominant-negative Egr-1 blocked DARPP-32 induction by BDNF. Together, this study identifies Egr-1 as a transcriptional activator of the Ppp1r1b gene and provides insight into the molecular mechanisms that regulate medium spiny neuron maturation.
Insights
Researchers identified Early Growth Response-1 (Egr-1) as a key protein that activates the Ppp1r1b gene, which codes for DARPP-32 (dopamine and adenosine 3′,5′-cyclic monophosphate regulated phosphoprotein, 32 kDa). This finding offers new insights into regulating medium spiny neuron development.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- DARPP-32 (dopamine and adenosine 3′,5′-cyclic monophosphate regulated phosphoprotein, 32 kDa) is crucial for signaling in medium spiny neurons.
- Understanding DARPP-32 gene regulation is vital for inducing striatal phenotypes in stem cells.
Purpose of the Study:
- To identify transcriptional mechanisms regulating striatal DARPP-32 expression.
- To characterize the role of specific DNA regions and interacting proteins in Ppp1r1b gene regulation.
Main Methods:
- Identification and characterization of a conserved region (H10) in the Ppp1r1b gene's intron IV.
- Protein complex purification and identification using nuclear extracts from rodent striata.
- In vitro and in vivo validation of protein-DNA interactions using super-shift and chromatin immunoprecipitation assays.
- Functional studies involving Egr-1 overexpression and dominant-negative inhibition in primary striatal neurons.
Main Results:
- A conserved DNA region, H10, in intron IV of the Ppp1r1b gene was identified.
- Early Growth Response-1 (Egr-1) was identified as a protein that binds to H10.
- Egr-1 binding to H10 was confirmed in vitro and in vivo.
- Brain-derived neurotrophic factor (BDNF) enhanced Egr-1 binding to H10.
- Egr-1 overexpression induced DARPP-32 expression, while dominant-negative Egr-1 blocked BDNF-induced DARPP-32 expression.
Conclusions:
- Egr-1 acts as a transcriptional activator of the Ppp1r1b gene.
- This study elucidates molecular mechanisms regulating medium spiny neuron maturation via DARPP-32.
- Findings contribute to understanding striatal development and potential therapeutic strategies.
